<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Hypocalcemia":1,
"Hypoparathyroidism":3,
"Parathyroid hormone":1,
"Thyroidectomy":6,
"Vitamin D":3,
"carbon nanoparticles":1,
"clinical lymph node metastasis":1,
"lymph node":2,
"papillary thyroid carcinoma":21,
"parathyroid":2,
"stochastic control":1,
"Tc99m sestamibi scintigraphy":1,
"primary hyperparathyroidism":1,
"thyroid disorder":1,
"thyroid pathology":1,
"ultrasonography":7,
"CD34":1,
"Myofibroblasts":1,
"Regeneration":1,
"Repair":1,
"Stromal cells":1,
"Telocyte hyperplasia":1,
"Telocytehyperplasia":1,
"Tumour stroma":1,
"FTO":1,
"cancer":6,
"meta-analysis":4,
"polymorphism":2,
"rs9939609":1,
"Total thyroidectomy":1,
"ectopic":1,
"goiter":1,
"retrosternal":1,
"thyroid":14,
"Intraoperative neuromonitoring":1,
"Prognostic value":2,
"Recurrent laryngeal nerve":1,
"Staged thyroidectomy":1,
"Thyroid surgery":3,
"DNA and RNA techniques":1,
"Thyroglobulin":2,
"tumour markers":1,
"Congenital cystic lesions":1,
"Lymph node metastasis":4,
"Pax8":1,
"TTF-1":2,
"Black thyroid":1,
"Fluorescence imaging":1,
"Indocyanine green":1,
"Minocycline":1,
"Thyroid pigment":1,
"AFTN":1,
"Hyperthyroidism":1,
"Radiofrequency ablation":2,
"Thyroid nodules":4,
"Ultrasound-guided procedures":1,
"FOXP3":1,
"differentiated thyroid cancer":3,
"single nucleotide polymorphism":1,
"Cost effectiveness":1,
"Decision analysis":1,
"Thyroid nodule":9,
"Cowden syndrome":1,
"Oral hamartomas":1,
"Oral papules":1,
"Children":3,
"papillary thyroid cancer":5,
"pediatric thyroid cancer":1,
"puberty BRAF mutation":1,
"Bone":1,
"Cementoplasty":1,
"Interventional oncology":1,
"Stent":1,
"Cancer stem cells":1,
"GANT61":1,
"Hedgehog pathway":1,
"Paclitaxel":1,
"Triple-negative breast cancer":2,
"Clinical implication":1,
"Extrathyroidal extension":2,
"Recurrence":3,
"Computer-assisted interventions":1,
"Electromagnetic tracking":1,
"Gelatin phantoms":1,
"Aberrant surgical anatomy":1,
"Clinical case":1,
"Neck surgery":1,
"Right subclavian artery":1,
"Breast cancer":10,
"HIF-1α":1,
"Hyperinsulinemia":1,
"Oxidative stress":1,
"Type 2 diabetes mellitus":1,
"Endoscopic parathyroidectomy":1,
"Focused parathyroidectomy":1,
"Minimally invasive parathyroid surgery":1,
"delayed recovery":1,
"dynamic risk stratification":1,
"thyroid cancer":20,
"thyrotrophin":1,
"BRAF":2,
"CD70":1,
"PDL1":1,
"anaplastic thyroid cancer":1,
"immunotherapy":1,
"frozen section fine-needle aspiration biopsy":1,
"papillary carcinoma":3,
"catechol estrogen-3,4-quinones":1,
"depurinating DNA adducts":1,
"dopamine 3,4-quinone":1,
"ABCG2":1,
"Cancer stem cell":1,
"MRP1":1,
"Solid variant":1,
"NSCLC":1,
"Radiation":1,
"Screening criteria":1,
"Smoking":1,
"Survivor":1,
"incidental findings":1,
"low-dose computed tomographic scans":1,
"lung cancer screening":1,
"screening":1,
"Oncogene":1,
"ZCCHC12":1,
"111In-octreotide":1,
"68Ga-DOTATATE":1,
"Medullary thyroid carcinoma":9,
"Positron emission tomography":1,
"Asian populations":1,
"cohort study":2,
"immigrants":1,
"incidence":1,
"Acral melanoma":1,
"Biomarkers":1,
"Chinese patients":1,
"Ipilimumab":1,
"Mucosal melanoma":1,
"Pembrolizumab":1,
"Cytology":2,
"papillary carcinoma thyroid":1,
"warthin-like papillary carcinoma of thyroid":1,
"acoustic radiation force impulse":1,
"elastography":2,
"malignancy":1,
"sonography":1,
"Cancer predisposition syndrome":1,
"Cystic nephroma":1,
"DICER1":1,
"Imaging":1,
"Pineoblastoma":1,
"Pleuropulmonary blastoma":1,
"Atypia or follicular lesion of undetermined significance":1,
"Fine-needle aspiration":3,
"Subclassification":1,
"Hashimoto's disease":1,
"anti-thyroglobulin":1,
"Anti-thyroglobulin antibodies":1,
"Radioactive iodine ablation":1,
"microcarcinomas":1,
"surveillance for microcarcinomas":1,
"CT scans":1,
"cross-sectional anatomy":1,
"ethnic group":1,
"neck surface anatomy":1,
"cardiovascular disease":1,
"racial differences":1,
"survivorship":1,
"Afirma":1,
"gene expression classifier":1,
"indeterminate thyroid nodules":2,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":2,
"dual malignancy":1,
"small lymphocytic lymphoma":1,
"thyroid fine needle aspiration":1,
"inflammation based score":1,
"plasma fibrinogen":1,
"platelet-to-lymphocyte ratio":1,
"prognostic nutritional index":1,
"lymph node metastases":2,
"reporting":1,
"ultrasound":2,
"HCC":1,
"dose finding":1,
"hepatocellular carcinoma":2,
"lenvatinib":2,
"pharmacokinetics":1,
"ATA guidelines":1,
"incidental lymph nodes":1,
"Intraoperative nerve monitoring":1,
"Recurrent laryngeal nerve injury":1,
"adenocarcinoma":1,
"dogs":1,
"immunohistochemistry":2,
"lung neoplasms":1,
"napsin A":1,
"squamous cell carcinoma":2,
"surfactant protein A":1,
"thyroid transcription factor-1":2,
"Pituitary adenoma":2,
"adolescents":1,
"apoplexy":1,
"headache magnetic resonance imaging":1,
"panhypopituitarism":1,
"pituitary abscess":1,
"Central neck dissection":1,
"Elective":1,
"Locoregional recurrence":1,
"Survival":2,
"fine needle aspiration":3,
"intraoperative frozen section":1,
"Calcium signaling":1,
"Cytoskeleton":1,
"Gene expression":1,
"Human health risk assessment":1,
"Mode of action":1,
"extranodal extension":1,
"nodal metastasis":1,
"prognostic factor":1,
"cardiac death":1,
"cardiac disease":1,
"lung cancer":2,
"Iodine-131":1,
"Radioiodine therapy":3,
"Remnant ablation":2,
"ThyroSeq":1,
"cytomorphology":1,
"fine-needle aspiration (FNA)":1,
"molecular":1,
"parathyroid hormone (PTH)":1,
"Pediatric":1,
"Tongue base":1,
"Transoral robotic surgery":1,
"FDG-PET":1,
"differential diagnosis":1,
"malignant tumours":1,
"sialadenoma papilliferum":1,
"Phase II clinical trial":1,
"anaplastic thyroid carcinoma":1,
"overall survival":1,
"progression-free survival":2,
"sorafenib":1,
"TNM staging":1,
"prognosis":8,
"thyroid neoplasms":7,
"validation studies":1,
"Cytohistological correlation":1,
"Cytological variants":1,
"Fine needle cytology":1,
"MEN2":1,
"RET gene":1,
"Synonymous mutation":1,
"Fear of recurrence":1,
"Health-related quality of life":1,
"Patient Reported Outcomes":1,
"CASC2":1,
"Long noncoding RNAs":1,
"Thyroid carcinoma":3,
"Carcinoma Hürthle cell carcinoma":1,
"Follicular carcinoma":2,
"Long noncoding RNA":1,
"MALAT1":1,
"Oncocytic":1,
"P-mTOR":1,
"miR885-5p":1,
"Alkylating chemotherapeutic agent":1,
"MNNG":1,
"MicroRNA-181b":1,
"PARP1":1,
"Cervical lymph node metastasis":1,
"Ethanol ablation":1,
"Percutaneous ethanol injection therapy":1,
"Recurrent papillary thyroid carcinoma":1,
"Phase 3":1,
"multitargeted kinase inhibitor":1,
"Aberrant right subclavian artery":1,
"esophageal cancer":1,
"non-recurrent inferior laryngeal nerve":1,
"thoracoscopic esophagectomy":1,
"follicular variant":1,
"quality assurance":1,
"Chromophobe renal cell carcinoma":1,
"Oncocytic carcinoma":1,
"Poorly differentiated carcinoma":1,
"Tuberous sclerosis complex":1,
"Breast disease":1,
"Epidemiology":1,
"Risk factors":1,
"Aspiration cytology":1,
"Flow cytometry":1,
"MALT":1,
"Thyroid lymphoma":1,
"κ/λ light chain ratio":1,
"Hashimoto’s thyroiditis":4,
"environment":1,
"Liver cancer":1,
"non-Hodgkin lymphoma":1,
"second malignant neoplasm":1,
"Bethesda classification":1,
"Fine needle aspiration biopsy":1,
"Frozen section":1,
"Indeterminate cytology":1,
"parotitis":1,
"radioiodine":1,
"sialoendoscopy":1,
"Akt-mTOR":1,
"Invasion":3,
"MREG":1,
"Proliferation":2,
"Histology":1,
"Minimally invasive extrathyroidal growth":1,
"Prognostic relevance":1,
"Residual tumor":1,
"TNM classification":1,
"ATA":1,
"K-TIRADS":1,
"NIFTP":1,
"follicular variant of papillary thyroid carcinoma":1,
"disease recurrence":1,
"low risk":1,
"thyrotropin suppressive therapy":1,
"cabozantinib":2,
"drug development":1,
"cancer survivorship":1,
"fatigue":1,
"physical activity":1,
"survey":1,
"AUS/FLUS":1,
"BSRTC":1,
"Bethesda System for Reporting Thyroid Cytopathology":1,
"atypia of undetermined significance or follicular lesion of undetermined significance":1,
"thyroid gland":2,
"Acinar":1,
"Galectin-4":1,
"Lung adenocarcinoma":2,
"Autoimmune thyroid diseases":1,
"Hyperprolactinemia":1,
"Prolactin":1,
"Prolactinoma":1,
"Branchial arch":1,
"Solid cell nest":1,
"Ultimobranchial body":1,
"Warthin tumor":1,
"Laparoscopic splenectomy":1,
"solitary splenic metastasis":1,
"clinical research":1,
"clinical trials":1,
"thyroid cancer — clinical":1,
"Retrospective study":1,
"TGF-β1":2,
"Triple negative breast cancer":1,
"Two-institutional":1,
"Biomarker":1,
"Enzyme-Linked Immunosorbent Assay":1,
"KLLN protein":1,
"PTEN protein":1,
"FNA":1,
"Nodule":1,
"Papillary cancer":1,
"Thyroid ultrasound":1,
"I-131":1,
"I-131 adjuvant treatment":1,
"Radioiodine refractory disease":1,
"Radioiodine scanning":1,
"Calcium":1,
"Micronutrient deficiency":1,
"Vitamin E":1,
"Zinc":1,
"Null cell adenoma":1,
"Pituicytoma":1,
"Pituitary neuroendocrine tumor":1,
"Silent subtype III adenoma":1,
"Chemoradiotherapy":1,
"Hyper fractionated radiotherapy":1,
"Pancreatic cancer":1,
"Proton beam radiotherapy":1,
"Unresectable cancer":1,
"Warburg effect":1,
"cancer biology":1,
"cancer metabolism":1,
"cancer therapy":1,
"energy metabolism":1,
"mitochondria":2,
"mitochondrial oxidative phosphorylation":1,
"pyruvate kinase M1":1,
"pyruvate kinase M2":1,
"ATA guideline":1,
"disease presentation":1,
"mortality":1,
"risk stratification":1,
"Chemotherapy":1,
"HBV/HCV reactivation":1,
"Hepatitis B virus (HBV)":1,
"Hepatitis C virus (HCV)":1,
"Toxicity":1,
"dabrafenib":1,
"intermittent dosing":1,
"trametinib":2,
"bronchogenic carcinoma":1,
"carcinoid syndrome":1,
"carcinoid tumor":2,
"flushing":1,
"gastroenteropancreatic neuroendocrine tumor":1,
"mastocytosis":1,
"pheochromocytoma":2,
"renal cell carcinoma":1,
"vasointestinal polypeptide–secreting tumor":1,
"Cardiotoxicity":1,
"Targeted therapy":1,
"Adequacy":1,
"Sensitivity":1,
"Cytopathology":1,
"Molecular testing":1,
"Secretory carcinoma of thyroid":1,
"Signet ring cells":1,
"Metabolism":1,
"Oncogenes":1,
"Lymphangiogenesis":1,
"Ovarian carcinomas":1,
"Microwave ablation":1,
"complications":1,
"nodule volume":1,
"reduction rate":1,
"thyroid function":1,
"iodine theranostics":1,
"redifferentiation":1,
"sodium–iodine symporter":1,
"PRRT":1,
"absorbed dose":1,
"dosimetry":1,
"radiobiology":1,
"theranostics":1,
"differentiated thyroid carcinoma":1,
"Oral cancer":1,
"Patient-reported outcome":1,
"Quality of life":1,
"Speech":1,
"Swallowing":1,
"Stereotactic radiosurgery":1,
"brain metastases":1,
"long-term survival":1,
"outcome":1,
"Metallothioneins":1,
"Splicing":1,
"miR17-92 cluster":1,
"miRNA":1,
"Magnetic resonance imaging":1,
"Thyroid neoplasm, carcinoma, papillary":1,
"Hypothyroidism":1,
"nivolumab":1,
"thyroid peroxidase":1,
"adrenal disorders":1,
"thyroid disease":3,
"clinical practice guideline":1,
"neck cancer":1,
"neck mass":1,
"Breast invasive ductal carcinoma":1,
"Clinical characteristics":1,
"Programmed death 1 ligand 1":1,
"Graves’ disease":1,
"autoimmune thyroid disease":1,
"Biopsy, fine needle":1,
"Gene":1,
"Mutation":1,
"Lung":1,
"Malignant glomus tumor":1,
"Trachea":2,
"Advanced stage":1,
"Deltopectoral flap":1,
"Neck dissection":2,
"Reconstruction":1,
"Calcinosis circumscripta":1,
"Panthera leo":1,
"lion":1,
"skin":1,
"tumoral calcinosis":1,
"Aesthetic principle":1,
"Minimally invasive access":1,
"POSAS":1,
"Antenatal, Antithyroid drug, Hyperthyroidism, Hypothyroidism, Thyroid cancer, Thyroid nodules, Lactation":1,
"anastomosis":1,
"carcinoma":1,
"circumferential sleeve resection":1,
"suprahyoid release":1,
"surgery":1,
"lysosome-associated protein transmembrane 4-β":1,
"susceptibility":1,
"transcription activity":1,
"nodular thyroid":1,
"ultrasound elastography":1,
"C-X-C chemokine receptor type 7":1,
"isobaric tag for relative and absolute quantification-coupled two-dimensional liquid chromatography-tandem mass spectrometry analysis":1,
"Hashimoto thyroiditis":1,
"bromocriptine":1,
"resistance to thyroid hormone":1,
"C-cells":1,
"Calcitonin":1,
"Calcitonin receptor":1,
"Population-based":1,
"Tyrosine kinase inhibitors":1,
"Vandetinib":1,
"Nano-diamino-tetrac":1,
"antiproliferation":1,
"resveratrol":1,
"tetrac":1,
"Clinical oncology":1,
"Endocrine surgery":1,
"Thyroid disorders":1,
"C634Y":1,
"D707E":1,
"MEN2A":1,
"double mutation":1,
"Hürthle cell neoplasm":1,
"thyroid follicular neoplasm":1,
"hepatitis c":1,
"unwanted effects / adverse reactions":1,
"Goiter, nodular":1,
"Tomography, X-ray computed":1,
"endocrine cancer":1,
"CASTLE":1,
"case report":2,
"radiation therapy":1,
"thyroid tumor":1,
"Metastasis":1,
"BET protein inhibitors":1,
"BET proteins":1,
"Chromatin modifications":1,
"Epigenomics":1,
"Histone deacetylase inhibitors":1,
"Histone deacetylases":1,
"JQ1":1,
"Breast neoplasms":1,
"Consensus":1,
"Interdisciplinary communication":1,
"fine-needle aspirates":1,
"intraoperative thyroglobulin measurement":1,
"preoperative ultrasonography":1,
"predictive factors":1,
"recurrent laryngeal nerve invasion":1,
"Chromogranin A":1,
"Markers, Tumor":1,
"Neuroendocrine Tumor":1,
"Europe":1,
"Population-based cancer registry":1,
"Rare cancers":1,
"FISH":1,
"MTC":1,
"RAS":1,
"RET":1,
"Eosinophil cationic protein":1,
"Interleukin 5":1,
"Radioactive iodine":1,
"AR42J cell":1,
"Aminoguanidine":1,
"MAPK signaling":1,
"cell function":1,
"effect on mechanisms":1,
"lipid peroxidation":1,
"Granuloma":1,
"Nocardia":1,
"Metastases":1,
"Post-thyroidectomy thyroid storm":1,
"Thyrotropin receptor antibodies":1,
"PD-L1":1,
"TIL":1,
"TNBC":1,
"Notch3":1,
"epithelial-mesenchymal transition":1,
"estrogen receptor α":1,
"luminal phenotype":1,
"Breast tumor":1,
"Papillary breast carcinoma":1,
"Tall cell variant":1,
"BRAFV600E":1,
"chromosome 5":1,
"combined therapy with vemurafenib and palbociclib":1,
"drug resistance":1,
"papillary thyroid cancer preclinical model":1,
"PSM":2,
"SEER":2,
"mixed subtype thyroid carcinoma":1,
"Autopsy":1,
"Diagnostic techniques and procedures":1,
"X-linked inhibitor of apoptosis protein (XIAP)":1,
"anaplastic thyroid carcinoma (ATC)":1,
"migration":2,
"oxyphilic thyroid carcinoma":1,
"child":1,
"treatment":2,
"MCL-1":1,
"TRAIL":1,
"c-met":1,
"miR-101":1,
"ASD: Autism spectrum disorder":1,
"ATP: Adenosine triphosphate":1,
"ENCoM: Elastic network contact model":1,
"GROMACS: Groningen machine for chemical simulations":1,
"LINCS: Linear constraint solver":1,
"MD: Molecular dynamics":1,
"NMA: Normal mode analysis":1,
"PCA: Principal component analysis":1,
"PDB: Protein data bank":1,
"PHTS: hamartoma tumor syndrome":1,
"PIP: Phosphatidylinositol-3,4,5-triphosphate":1,
"PIP: Phosphatidylinositol-4,5-biphosphate":1,
"PME: Particle mesh Ewald":1,
"PTEN":1,
"PTEN: Phosphatase and tensin homolog deleted on chromosome ten":1,
"RMSD: Root mean square deviation":1,
"Rg: Radius of gyration":1,
"VMD: Visual Molecular Dynamics":1,
"WT: Wild-type":1,
"autism":1,
"molecular dynamics simulations":1,
"poly(Glu-pTyr): Polymers of glutamate and tyrosine, 1:1 ratio":1,
"protein structure stability":1,
"Chinese population":1,
"cancer susceptibility genes":1,
"germline mutations":1,
"multiple-gene sequencing":1,
"clincopathological character":1,
"conventional thyroidectomy":1,
"effectiveness":1,
"minimally invasive video-assisted thyroidectomy":1,
"safety":1,
"recurrent laryngeal nerve palsy":1,
"postoperative pain":1,
"IQGAP":1,
"Mass spectrometry":1,
"Proteomics":1,
"Axillary lymph nodes":1,
"Ki-67":1,
"Luminal B HER-2 negative":1,
"PR status":1,
"Prognostic index":1,
"circulating tumor cell":1,
"follicular adenoma":1,
"peripheral blood":1,
"Bone and soft tissue":1,
"Neuroendocrine neoplasms":1,
"Neuroendocrine tumors":1,
"Soft tissue":1,
"Afirma gene expression classifier":1,
"Follicular variant of papillary&nbsp":1,
"thyroid carcinoma&nbsp":1,
"(FVPTC)":1,
"Noninvasive follicular thyroid&nbsp":1,
"neoplasm with papillary-like nuclear features&nbsp":1,
"(NIFTP)":1,
"Papillary thyroid carcinoma (PTC)":1,
"Thyroid fine needle aspiration (FNA)":1,
"HePTP":1,
"Wnt/β-catenin":1,
"chemokine":1,
"cytokine":1,
"BANCR":1,
"Luteolin":1,
"TSHR":1,
"Papillary thyroglossal duct carcinoma":1,
"diagnosis":1,
"head and neck neoplasms":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年9月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
